mounjaro tirzepatide patent expiry us Eli Lilly launches weight-loss drug in India, beats Novo Nordisk to major market Ozempic's Patent Protection Starts to

Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Adakveo (crizanlizumab-tmca) to reduce the frequency of vasoocclusive crises in patients with sickle cell disease

Bone health in adults with obesity before and after interventions to promote weight loss

If you truly cannot eat solid food in the morning, a protein shake is acceptable

This is the first time a GLP-1 receptor agonist for obesity has been available in pill form no injection, no refrigeration required

After weaning, the pups ate either a standard diet or one supplemented with 1.5% okra powder

What Comes After Tirzepatide